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According to the 2000/2001 Zambia Demographic and Health Survey (ZDHS), 
HIV / AIDS prevalence is 16% and is expected to be higher in the next five years. The 
disease is quite pervasive across all sectors of economic activity, but the impact is 
especially acute on the Zambian health sector, which is faced with increasing demands on 
healthcare for not only HIV / AIDS but other diseases such as malaria, tuberculosis, 
cholera, diarrhoea, to mention but a few. It is therefore essential that expenditure on HIV-
related care among different health care systems be analysed so as to determine areas of 
relatively greater need. It is against this background that this study entitled, "An analysis 
of expenditure on HIVIAIDS patients in Zambia ", was conducted. 
The main objective of the study is to analyse expenditure on HIV -related care and 
treatment among the different health care systems and geographical localities in Zambia. 
The study used utilisation data on total and HIV -related outpatient visits and inpatient 
days collected from the country's facility based database called the Health Management 
Information System (HMIS); and HIV-prevalence data compiled from the Central 
Statistics Office's report on Epidemiological Projections. Expenditure data on the other 
hand was compiled from the National Health Accounts (NHA) report for 1999-2002 and 
separate data on HIV / AIDS expenditure was collected from the District Health Boards 
reports for 2003. Utilisation and HIV -prevalence data were then combined with 
expenditure data to estimate the overall utilisation of services by HIV -positive patients 
and the annual expenditure required to meet the burden of HIV / AIDS. Both utilisation 
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Chapter overview: This chapter provides the background to the study. The Chapter 
also outlines research problem, study justification and its objectives. 
1.1 Introduction 
Many countries in Africa are increasingly pressured to expand their health care services 
to combat a growing burden of disease-and to do this as limited, and even declining and 
unreliable public funding, forces rationalisation of service delivery. As many countries 
continue to struggle and population keep growing, the challenges of providing health care 
services to all increase. In East and Southern African (ESA) countries in general and 
Zambia in particular, this situation is exacerbated by additional demands placed by the 
HIV I AIDS epidemic and associated increases in opportunistic infections such as 
tuberculosis, on the health services (Loewenson and Whiteside, 1997). 
Zambia has one of the highest HIV prevalence among the Sub-Saharan African countries. 
With an HIV prevalence of 16% (CSO, 2003), the epidemic has not only resulted in high 
morbidity and mortality among the population but it has also posed complex challenges 
because resources are limited, costs of health care are high and the number of cases 
continue increasing (MoH/CBoH, 2003). The economic impact of HIV/AIDS is quite 
pervasive with virtually all sectors of economic activity and segments of society affected 
by the disease. Health, education, labour force, defence, agriculture and transport are 
among the sectors of economic activities affected. According to a report by 
UNAIDSIWHO (1999), in the majority of African countries, internal contributions to the 
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Due to the limited nature of government resources and the unlimited nature of public 
needs, HIV I AIDS services and their delivery must be selected to fit, among other things, 
within the context of available resources. 
The limited funds allocated to the health sector in the country towards HIV -related 
treatment can be utilised more efficiently and effectively if the likely expenditure on 
HIV/AIDS patients is known, to guide evidence-based decision-making. 
1.3 Study objectives 
1.3.1 General objective 
The study analysed expenditure on HIV -related care and treatment among the different 
health care systems and geographical localities in Zambia. 
1.3.2 Specific Objectives 
(i) To estimate the cost per outpatient visit and inpatient day at different 
levels of health care; 
(ii) To calculate outpatient visits per capita and inpatient days per capita in 
different provinces; 
(iii) To estimate annual HIV -related expenditure for outpatients and inpatients 
by different levels of care; 
(iv) To estimate the projected expenditure for HIV -related care by 
geographical localities. 
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particular emphasis on different health care systems, the problem of HIV I AIDS and 
government response to it. The Chapter ends by providing an overview of some 
constraints in the delivery of HI VIA IDS services in the country. 
Chapter Three reVIews the literature on HIV/AIDS expenditure, National Health 
Accounts and cost and cost-effectiveness analyses. It provides an overview of previous 
studies conducted by focusing on the methods used in estimating some output measures. 
Chapter Four examines the methodology used in the study, data collection methods, 
data sources and how data were analysed. 
Chapter Five presents results of the study. Unit cost per inpatient day and outpatient 
visit at different levels of health care is presented. It also provides an estimate of 
HIV/AIDS expenditure per capita and projected annual expenditure, according to 
geographical localities. 
Chapter Six discusses study results with particular focus on key selected indicators. It 
discusses surrunary findings compared by different provinces and at different levels of 
care. 
Lastly, Chapter Seven makes some concluding remarks on study results; outlines study 
limitations and makes some policy recorrunendations. 
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Chapter overview: This chapter provides an overview of the geography, demographics 
and macro-economic indicators of the country. It also outlines different health care 
systems in Zambia, the problem ofHIV/AIDS and government response to it. 
2.1 Background 
Zambia is a land-locked country covering an area of 752,612 square kilometers (about 
2.5 percent of Africa) and shares borders with the Democratic Republic of Congo (DRC) 
and Tanzania in the north, Malawi and Mozambique in the east; Zimbabwe and 
Botswana in the south, Namibia in the southwest and Angola in the west (CSO,2000). 
Figure 1: Map of Zambia showing neighbouring countries 
I 
2$ 
DE O CRATIC 
REP B C OF TH 
CONGO 
Source: CSO, 2000 















1 1 HUILlVJIHU censuses 
at an 
IS IS 













An analysis of expenditure on HIV/AIDS patients in Zambia (Masters Dissertation) 
net, and have been accompanied by GDP growth in real terms at an estimated 6.8% in 
1993 and 4% in 1994. The huge external debt remains a key problem (ibid). 
In 2001, the World Bank estimated Zambia's per capita Gross Domestic Product (GDP) 
at US$350. Over the years, debt service has on average accounted for 10% ofGDP, while 
all the social sectors together have accounted for only 5%. The debt is owed primarily to 
multilateral institutions. In December 2000, Zambia was approved for debt relief under 
the enhanced Debt Initiative for Highly Indebted Poor Countries (HIPC). Zambia's debt 
stock is likely to remain unsustainable even with HIPC debt relief (Ibid). 
2.5 Health 
2.5.1 Zambian Health Sector Reforms 
In the past decade, many less developed countries have been attempting to improve the 
performance of their health delivery systems. Like other countries, Zambia was prompted 
by similar circumstances to embark on a national health reform program. One of the 
reasons for health reforms was the decline in the general health status of the population 
accompanied by reduced availability of resources for health (Church and Simwanza, 
2000). 
Because of the ensuing "health care crisis" in the country, it became necessary to find an 
effective way of stopping the situation from deteriorating any further. Therefore, in 1991 
the Government of the Republic of Zambia came up with the current health reform 
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In Zambia, HIV/AIDS remains an overwhelming development challenge with women 
and urban residents disproportionately affected by the disease (CSO, 2003). Table 1 
shows HIV prevalence among adults in rural and urban areas and by gender. The Table 
shows that prevalence is higher in urban than rural settings and according to gender, it is 
higher among females than males. 





Source: CSO, Demographic and Health Survey, 2003 
2.5.5.1 ART program in Zambia 
Recognising that Highly Active Antiretroviral Therapy (ART) can delay progress of 
HIV I AIDS, allowing people living with the disease to live longer, healthier and more 
productive lives than would be the case without it; Zambian Government made a policy 
decision to make ART services widely available to all its citizens. In 2003, the Zambian 
government allocated about US$3million for the purchase of ARV drugs for 10,000 
People Living with HIV I AIDS (PL WHA) to be provided through the public health 
facilities (Central Board of Health et ai, 2004). 
Zambia is one of the first countries to respond to WHO's call for countries to request for 
assistance to be supported with scaling-up access of ART, in the context of the 
WHO/UNAIDS-Ied global target of providing 3 million people on treatment by the end 
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responsibilities of the task forces are not clearly defined due to lack of national guidelines 
{ibid}. 
Thirdly, much stigma is still associated with HIV / AIDS thereby limiting the number of 
people who seek HIV testing and care. 
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Chapter overview: This chapter reVIews literature on National Health Accounts 
(NHA), cost and cost-effectiveness studies conducted III general and on HN-related 
treatment in particular. The Chapter is divided into three sections. Section 3.1 provides a 
brief description of key concepts used in the studies. Section 3.2 reviews the studies 
conducted by focusing on the methods used and how certain output measures were 
calculated. The Chapter ends with section 3.3, which provides some concluding remarks 
of the studies conducted. 
3.1 Brief description of key concepts used in the studies 
o Full costing values the opportunity cost of all resources required to deliver a 
servIce; 
o Incremental costing involves calculating the costs of extra resources incurred 
such as when an extra service is added onto an existing package; 
o The ingredients approach to calculating costs involves the identification of 
specific 'ingredients' directly involved in delivering a specific service, and 
links these ingredients to the cost of each ingredient; 
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Results of the study showed that HIV I AIDS expenditure per capita for the entire 
population in 1998 was: Brazil US$2.69, Mexico US$1.25, Guatemala US$1.08, 
Uruguay US$6.63 and Honduras US$6.63 (ibid) . 
Barnet et at (2001) conducted a study to estimate expenditure on HIV/AIDS in Rwanda 
for 1999 and 1998 using the National Health Accounts (NHA) framework. Data was 
collected from public and private sector organisations and agencies involved in 
HIV I AIDS activities. HIV I AIDS expenditure was defined as expenditure that has a direct 
impact on the prevention, management and treatment of HIV I AIDS. Other data was 
collected on household spending using a questiOIUlaire that gathered information on the 
use of inpatient and outpatient health services, number of days spent in hospitals and cost 
of medication purchased (ibid). 
A comparison of HIV I AIDS -related costs (prevention, treatment and mitigation) to the 
overall health expenditure, revealed that AIDS prevention was primarily financed by 
donor funds, whereas treatment costs place the heaviest financial burden on households. 
This is because no financial support systems exist to facilitate patient's access to care. 
3.2.2 Cost analyses of treatment for HIV I AIDS 
Bautista (2002) conducted a study in Mexico to look at costing public sector HIV/AIDS 
treatment. The main objective of this study was to document the Mexican experience in 
HIV/AIDS treatment in three different health systems - the Ministry of Health, the 
Mexican Social Security Institute and the National Institute of Health. 
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3.2.3 Cost-effectiveness analyses of treatment for HIV/AIDS 
In Cost-effectiveness studies, the costs of two or more programmes, from a particular 
view point, are compared to the health effects of these programmes, where the health 
effects are measured in natural units such as cases cured, lives saved and cases of 
diseases averted. The results are expressed as incremental cost per unit of additional 
, 
effect (Drummond, 1997). 
A study conducted by Cleary et al (2004) in a South African Township, looked at the 
cost-effectiveness of antiretroviral treatment for HN -positive adults. The study was 
conducted in three HN - dedicated clinics in Khayelisha, a township in Cape Town, 
South Africa. The main objective of this study was to describe the cost-effectiveness of 
providing ART in a poor public health sector setting, in terms of the economic cost per 
life year gained and quality adjusted life year gained and describe the lifetime costs for 
those on ART and those not on ART. 
Patient specific items (radiology, laboratory, investigations and medicines) were 
calculated using the ingredients approach based on utilisation by a sample of patients. 
The remaining cost per inpatient day or clinic visit relating to overheads and capital costs 
was allocated to patients using a step-down methodology. 
The PDE was calculated by applying a weighting factor of 0.27 and was used to calculate 
the overhead or hotel cost per inpatient day after excluding patient specific items from 
expenditure at a given health facility. Results of the study showed that lifetime costs for 
those on ART were approximately R93,000 compared to R23,000 for those not on ART. 
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Another cost analysis conducted by Kumaranayake and Watts (200 I) looked at the costs 
of scaling up priority health interventions in low-income and selected middle-income 
countries. The specific aim of this study was to conduct a full cost analysis of scaling-up 
the implementation of priority programmes designed to address the causes of major 
disease burden among people in low and middle-income countries, in order to maximise 
health outcomes. These programmes included TB treatment malaria prevention and 
treatment; HIV prevention, care and treatment; treatment and immunisation of childhood-
illnesses and maternity-related illnesses. The cost of scaling-u/ these programmes 
reflected how much it would cost the health care system to extend coverage for the main 
diseases and other health conditions. 
Study results showed that annual incremental cost of scaling up programs were about 
three times higher in low-income countries (US$IO billion) than in middle-income 
countries (US$3billion). In addition, out of all the intervention program areas, 
incremental cost of scaling up the intervention was highest for HIV prevention (3.6 
billion) followed by treatment on child related illnesses (US$I.7 billion). 
3.3 Conclusion 
The literature review has shown that a number of countries have attempted to estimate 
expenditure on HIV / AIDS in their efforts to develop appropriate responses to the 
epidemic and that methodologies of estimating costs were similar for all the studies 
1 Scaling-up refers to increasing the level of coverage of HIV activities from current levels as well as 
expanding the type ofHIV/AIDS programs (Kumaranayeke, 2001). 
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4.3.1 Financial data sources 
Resources for the treatment of HIV -positive people in Zambia are derived from the 
general pot of resources allocated to public health facilities. Additional earmarked HIV 
funds are also allocated to the health sector, but it cannot be guaranteed that these are 
only spent on HIV -related treatment and prevention activities. It was therefore necessary 
to collect data on total health service financing as well as separate data on HIV I AIDS 
financing. This included expenditure data from the 1999-2002 National Health Accounts 
(NHA) report and separate data on HIV/AIDS expenditure. Initially, it was hoped that 
expenditure data would be derived from the Financial Management Administration 
System (F AMS). However, this data was fragmented and incomplete for the year 2003. 
Therefore, 2002 NHA expenditure data was inflated to 2003 using the inflation rate of 
17.5% (MoHiCBoH Mid term Review Report, 2004). The NHA figures included 
expenditure on personnel, drugs, medical supplies and other costs required for the smooth 
operation of the health facility and would therefore include resources for treatment of 
HIV -positive people. 
The other source of financial data was collected from the 2003 District Health Board 
reports and covered funds allocated for HIV related activities. These funds are an 
aggregation of both government and donor funds and are allocated for treatment and 
prevention activities. As noted above, it cannot be guaranteed that these funds are spent 
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4.3.3 Estimation of unit cost for inpatients and outpatients at 
different levels of health care 
In most studies conducted (Flessa and Dung, 2004; Wamukuo and Ntutela, 2002) 
inpatients and outpatients were split by applying the patient day equivalent (PDE) and 
using a weighting factor of 0.3 on the assumption that it costs three times as much to 
offer inpatient care compared to outpatient care. This reasoning has been used to estimate 
the unit costs of inpatients and outpatients at different levels of health care by splitting 
total expenditure between outpatient visits and inpatient days using the patient day 
equivalent (PDE) and a weighting factor of 0.3 as follows: 
For inpatients: 
Therefore, Unit cost(lnpalients) = (Annual expenditure in a given level of health care) 
PDE(lnpatienls) 
For outpatients: 
f' · ··· · ~:~~~~~~~~i~~~~ ·~···~~~:~~::·~~· ·:·I~·I~~~ .. ~··(·i~~~t·i~~t .. ~~:~·~··~~i:~·~i·~~·;~~·t~~;·; ···~~~~~··~~:··~~i·~~·~:~~ ··;~~t~~ .. :~··~· ···· ·· ·· ·· ·· · ··· ··· ·· 
I Therefore, Unit cost(oulpatienls) = (Annual expenditure in a given level of health care) I 
; PDE(oulpalients) 1 
L ..................... n ................. . . . ......... . . ... ... ..... ...... ............ . . . ....... . . ... .......... ............... . .. ............................ ..... .. . ....... .. . . ...... ...................... . ... . . . ... . .. .. . ....... . ......... . ................... . . ......... . ...... . . . .. . .. : 
4.3.4 Estimation of annual HIV/AIDS expenditure at different levels 
of care for inpatients and outpatients 
In estimating the annual HIV/AIDS expenditure at different levels of care for both 
inpatient and outpatients, the unit cost calculated in Section 4.3.2 for each level of care, 
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Chapter overview: This chapter provides an overview of study findings. Unit costs per 
inpatient day and per outpatient visit at different levels of the health care system are 
estimated. The chapter also outlines an estimate of HIV/AIDS expenditure per capita at 
levels of care and geographical locality. 
5.1 Total NHA expenditure and HIV/AIDS expenditure at different levels 
of care and geographical locality 
This section presents summary information on total health expenditure collected from 
Zambia's NHA report covering the period 1999-2002 and that on HIV/AIDS expenditure 
collected from the District Health Boards reports. It provides health expenditure figures 
for 2003, projected from the NHA report using the end of year inflation rate of 17.5% 
(MoH, Mid Term review report, 2004). The section also presents an aggregate of the 
NHA and HIV I AIDS expenditure by different levels of the health system together with 
some explanations of what is contained in the totals for each of them. 
In order that we make compansons with results of other studies conducted, all 
expenditure data were converted from the local currency (Zambian Kwacha) to the 
United States Dollars (US$) using an exchange rare for 2003 of 1 US$ =ZMK4,800. 
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However, it cannot be guaranteed that these funds are spent solely on HIV -related 
activities. Therefore, it would be more accurate to consider that part of the "HIV I AIDS" 
expenditure spent on HIV -related activities, but there is no data on how much is spent. 
Table 2 below presents data on trends of total NHA expenditure for the period 1999-2002 
and the 2003 projected NHA figures at different levels of health care. The inflated NHA 
expenditure figures were added to the HIV/AIDS figures to get the overall health 
expenditure for 2003. 
;'ii[l1f.Gr,-~-- -'ii(fi'ij ~~~ ,I" ,~~,:r,nR .:,Yi : ,I~~'"j irf~':1)ij~(i,'!liiIt1t!~~,'{!1[i(:i':f~1(r,{G~(r,rR~f{~ 'mnE:' ~r ~ • ~ 
~ - - -- --- -- -- '- - . --_ .... - - - - ... ----- - - - - - - - - ~ ~ 
, :-~'"::r'~(.f ;,'nf~ :3.~lc'f:'(.T:,i,~';-_I:~\!@-i;{lTrlr0i.1r~I-!I:.(1.(~~Xl~l: ~j?::;-~ruJ~~1~1;/ 'iT]l(~-:-,!,:] 
': ' It~:O!.('~l~ldJ.r.~; . .'::. ... ..f.i," l(~:J(';j:filIF' : , 
,~.~- ....... ~- - -- -- -' - -- --'-- -----'--" ---- -- -- --





Year (US$' millions) (ZMK' (ZMK'millions (US$' millions) (ZMK' 
Source: Zambia's NHA report for 1999-2002 
.. These figures were projected using the 2003 end of year inflation rate of 17,5% 
First Level Hospitals Second Level Hospitals Third Level Hospitals 
0--;';;;-- '_~~~_~~~:~o~_I~_~;~;i~~ -~~~~~~~-I-~-~~~;;~~~~~~ (ZMK' mil~i;':~4 -1' (US$'I:,~lions) 
Source: CBoH, District Health Boards Financial Repons, 2003 
First Level Hospitals Second Level Hospitals Third Level Hospitals 
Grand Total (ZMK'millions) (US$' millions) (ZMK'millions (US$' millions) (ZMK' millions) (US$' millions) 
Projected + 
HlV/AIDS 50,564 10.5 136,253 28.4 366,143, 76.3 
expenditure 
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5.1.2 Total expenditure by levels of health care and provinces 
In order that we have an idea about the variations within and across different levels of 
health care and geographical localities (provinces), total health expenditure by provinces 
and different levels of health care was collected. This information is presented in Table 3. 
Note that the total health expenditure presented is an aggregate of the projected NHA 
expenditure for 2003 and HIV/AIDS expenditure, for the same period under review. 
Fint l.evel Hospitals Second l.evel Hospitals Third l.evel Hospitals 
Province (ZMK' millions) (USS' millions) (ZMK' millions) (USS' millions) (ZMK' millions) (USS' millions) 
. Lusaka------- 1----.-.-.----;-1--.-.--.... --.---;-----... ---.-.-----.. -.-----;- 1-'-'---298,161 62.1 
Nortiien'---- -'-'--12-;4i-if ---------"2.6-- 20,893 -----~4- ----:*-:-* -+-----.-----;;-
~o-rth--W-e-stern-··· ·--···---····----:8-=-58-=- -----·--6:i,...-+-------:1-,-8~945~---··---3.-9 .. -----.-.------:*-:-*-+---.-.----:-*:-:-* 
-SO-uth-ern--------.-14;684-1------3J --····---c2,...,4,-=-74C"C7c+------5=-=.2:- -------.--.- ** ** 
'-Western --- ·-----·----:;37- ----·-oT -----·--c-16c-,0=73,.-i-·---·---3.3· --.-- .. ---.----:**-+------:*-:-* 
-- ~_ • ,I , ' ~ __ • I . .\;_.... ...,...... • .... -c""'_'~..' ......... I, - ~I-- ::: I ~"-;' - I I 'Ie: Jj~ '~\;.c;" -;;:--•. / I . --;; ,,""~"j,,-::' y(:r:J-
__ ~____ _ _ _ _ I •• _. _ .. _ .. _ _ __ L _ __ _ _ •• _ 
*Denotes that there are no First and Second Level hospitals in Lusaka province 
**Denotes that there are no Third Level Hospitals in the provinces indicated, hence no data collected 
5.2 Utilisation data for outpatient visits and inpatient days at different 
levels of health care and geographicallocaJity 
5.2.1 Distribution of outpatient visits and inpatient days by different 
levels of care 
Table 4 presents data on outpatient visits and inpatient days for all diseases, collected 
from the country's facility based Health Management Information System (HMIS). The 
table shows that three quarters of the outpatient visits to health facilities were at Third 
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Central 1,012,257 1,223,445 1.2 
. __ ._-_._------_ .. _._---_ .. _ ..... _--_ .. _  ... _-- ----_ .. _._-- ----_. __ .......•. _ ---_._-.•.... _ ...... . _ - ----
Copperbelt 1,581,221 2,220,218 1.4 
r-::.--.. ------.. - - --.- -.- I---... -- .... ------.- ---... --.. ---.. -----.--.- .... -.... --...... ---.. - .. ----- - -.-- .... -.-.-.---.----
Eastern 1,306,173 1,595,842 1.2 
-LU·ap~Ta----·····-·----- ---- --·- ··-·- -;i755s·f·--------· 827]4"9- -·- ·---T1-----
...... --.. _ .......... _---_._---_._---1--_._ ... __ ... _._----.----.... - -------... ----- .--... ---.--- - --
Lusaka 1,391,329 2,289,494 1.6 
-----... -.-... --.---.... . ·····- --·-·------I------·--·-----··---··I---·---·-c--- - - I 
Northern 1,258,696 1,053,295 0.8 
- North~weStem_----- -·-·- ---··-·--·-·-583:350 ---·---·- --828,622 1.4 
--So-ut-hem-----·--f-·-·- ···- -----·-I ,2- 1-2;\"24 . 1,545,507 1--· --·--' -.3- - ----
Western i65,088 ',028:1641----------:1 .. ""'.3- - - - - --
Zambia 9,885,591 12,611,736 
·Source: CSO Census of Population and Housing. 2002 
··Source: HMIS database. 2003(also refer to Appendix I on page 88) 
Basic formulas used to calculate outpatient visits per capita is as follows: 
YOutpatient visits per capita(oulpolients) = (outpatient visits for a given province) 
Total population of a given province 
1.3 
5.2.3 Calculation of inpatient day per capita by different provinces 
Infonnation on inpatient days and population size for each province was collected from 
the HMIS database and the 2002 Census of Population. Data on inpatient days and 
popUlation size of each province were used to calculate inpatient days per capita for each 
province. This infonnation is presented in Table 6 below. The table shows that, unlike the 
outpatient visits which were higher for urban than rural provinces, inpatient days per 
capita were higher in rural than urban provinces. 
This pattern of higher per capita inpatient days for hospitals in rural as opposed to urban 
provinces is mainly attributable to the longer length of stay at hospitals in the fonner. 
This could be attributable to the lower quality of care provided in rural facilities, 
implying that patients spend longer in hospital waiting to receive treatment, but also 
could be because patients have an incentive to remain in hospitals where they receive 
food and shelter. 
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5.2.4.3 Proportion of expenditure share by different levels of 
health care, 2003 
Figure 3 illustrates differentials in health expenditure patterns according to different 
levels of health care. The figure shows that in 2003, the highest expenditure was spent at 
Third Level Hospitals, representing more than half of the total health expenditure, 
followed by Second Level Hospitals who spent a quarter of the total expenditure and the 
lowest expenditure was by First Level Hospitals who spent about one fifth of the 
expenditure. 
Figure 3: Distribution of expenditure share by different levels of 







Source: Author's illustration using data collectedfrom the NHA report, 2003 
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5.3 Utilisation and expenditure data on HIV/AIDS at different levels of 
care and geographical locality 
This section presents summary infonnation on the distribution of HIV -positive people in 
each province. It also shows how the annual HIV I AIDS expenditure for inpatients and 
outpatients was estimated using the unit cost calculated in sections 5.2.4.1 and 5.2.4.2 
respectively. 
5.3.1 Distribution of total population and HIV/AIDS population by 
provinces, 2003 
Table 8 shows the distribution of the total population, population aged 14 to 49 years, and 
the HIV -positive population in the same age group. The Table shows that the national 
HIV prevalence in 2003 was 14.4% for people aged 14-49. Lusaka province had the 
highest HIV/AIDS prevalence in the country (20.7%) followed by Copperbelt (18.5%) 
and Southern province (16.2%). Rural provinces such as Central (14.8%), Eastern 
(13.2%), Western (12.6%), Luapula (10.6%), North-Western (8.6%) and Northern (8.0%) 
had the lowest prevalence. 
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5.3.2.2 Estimation of total annual HIV/AIDS expenditure by 
different levels of care (outpatients) 
Information on the estimation of HIV/AIDS expenditure for outpatients by different 
levels of health care is presented in Table 9b. The Table shows that out of the total 
estimated US$314,073 expenditure on HIV/AIDS for outpatients, the highest estimated 
expenditure was spent on Third Level Hospitals (64%) followed by that for Second Level 
Hospitals (25%) and the lowest being the First Level Hospitals (11 %). 
'(f;1f ----;Yj •. ,jrd~ iii ,t:d, 'I; " ... ~'llIt •. \,. '11 ... 1 IllIfl:i trl~': :'In'i-;~: .~:'~~".'-l li·II~I;' ,', ·,ILL1·.Jtl ~('\' .,( 
__ ~t lL;~Jji~ \ .. .,.i .. -.:. ~I.!I,· .~!l.!..~~1.~!L~'ty. 
Different levels of 
health care system 




---_. __ ... :;---:-;--/-
Second Level Hospitals 6.33 









._ .... - .. _ .. _ ... - ... - ......... _-... .---- .... - - - .. +-----:-:-c:-c-t- ------~~,..,_f----.... --- .. . 
Third Level Hospitals 13.12 15,264 200,264 64.0 
Total for all hospitals per year (outpatients) 100.0 
-. . .. " 
-:' ',," :\ "',(, 
* Source: Adaptedfrom Table 7b (column 7) 
• * Source: HMIS database. 2003 (also refer to Appendix Ion page 88) 
Basic formulas used to calculate Total estimated annual HIV/AIDS expenditure(oUlp<llienls): 
YTotal estimated annual HIV/AIDS expenditure(Oulp<llienls) = Unit cost(oulpalienls) X HIV/AIDS utilisation figures(oulp<llien,s) 
5.4 Estimation of HIV I AIDS expenditure per capita for the total 
population and HIV/AIDS positive population by province 
This section illustrates how HIV/AIDS expenditure per capita for inpatients and 
outpatients for the total popUlation and also the HIV positive popUlation by provinces 
was calculated. This information is presented in Tables lOa and lab. 
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5.4.2 Estimation of HIV / AIDS expenditure per capita for the total 
population and HIV positive population (outpatients) 
Table lOb illustrates how HNIAIDS expenditure per capita for the total population and 
HIV positive population by province was calculated. The Table shows a similar pattern 
of higher HIV/AIDS expenditure per capita for both the total population and HN 












In 2003 (oulpalients) 
Expenditure 
per caplu(oulpalienls) 




Central 1,012,257 87,435 14,239 0.16 r-:--- ---.- --.. - .-.f---.------.- --... _ _ ___ . ___ . __ . _ __ . ___ 1--. _ _ ... ______ .__ __-".:.0.::.:01'--_____ _ 
_ ~".~rbelt _._ .. _ __ ._ ~~~~~~~._ ... ___ J1!l2?l_~_. ___ .. _. _ .. __ ___ ______ 49,091_ ... _ _ .J!:.~ ...... __ _ Q,DJ 
Eastern 1,306,173 81 785 - - - ... - --... -
-L,;apul~------ ---=ns 353- ' _ ........ _:L:.. ___ .... _ _ .... _____ ____ ..l.O,592 f----.....9..:.!l.------. 0.01 .. - --
"GSa~-"---- -- '--j-j91329'- ___ .. ~,'!.~f _._E.~.?:4 _______ 0..:.2._5 _ ____ .. _____ 0.Q2 ____ _ 
-::-:-;. __ .. _ ' , _._. r--!.?7,9~ __ .. _ ._._ ... ~,38S. __ '-____ .~_ .. _. __ ._ .. _ .. ~_. _ _ ._ 
--:~~rthern __ .. _.... 1,258,696 ___ ___ 6.3..!~. ___ .. _ _____ ... ~.O,949 0.33 0.02 
North-Western 583,350 - .... ---- ---- --
-So;;ti;ern 27,5~_7 _ ___ 14,803 0.54 ____ 1 --__ ~0~.03~_ .. _ 
1,212,124 120,768 24,803 0.21 0.02 
Western 765,088 
58,347 12.600 0.22 0.02 
·Source: These figures were adapted from Table 8 Table 8 on page 57 
Basic formulas used to calculate expenditure per capiu (oulpalienls) for the toul population: 
y + 
Expenditure per caplu(oulpalienlsj for the HIV population = Total estimated annual fllV/ AIDS expenditure in 2oo3(oulpatientsj 
+ 
HlY population (14-49 years group) 
~xpenditure per caplu(oulpalienls) for the toul population = Total estimated annual HlY/AIDS exoenditure in 2(XJ3 (oulpalienlsj 
Total population 
5.5 Total number of projected AIDS deaths (14-49 year age group) by 
provinces, 2003-2005, both sexes, Zambia 
Table 11 presents data on total projected number of HIV/AIDS deaths for the 14 to 49 
year age group, from 2003-2005 (CSO Epidemiological Projections, 2003). The Table 
shows that, a higher proportion of deaths are in the Copperbelt province (30%) followed 
by Lusaka province (17%), during for the period 2003-2005. 
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5.5.2 Calculation of projected expenditure for 2004 by provinces, 
(inpatients) 
According to the Central Statistical Office's Epidemiological Projections (CSO, 2003), 
the death rate of the Zambian HIV epidemic is set to peak in 2004 and 2005. Therefore, 
in order to meet future needs for care, we projected the expenditure requirements for 
2004 on the assumption that the number of patients needing care in 2004 is equal to 
HIV/AIDS deaths in 2004 and 2005. The projected expenditure for 2004 was calculated 
by multiplying expenditure per capita for total projected deaths for the years (2003 + 
2004) of each province by projected deaths for (2004 + 2005) of that particular province. 
Results of the projected expenditure by province (inpatients) for the year 2004 are 
presented in the last column of Table 12b presents. 
r , 1;·; [. l' 'Wn,;; I~' ~I\'~;-d ... , .. ;..,. 1';:'1~i_' (.)~'-. r .".') I'll,) i 
.--
: "A i) ':; Ii I ... 'J i. I _}~ n ~ I , ! i; 1 ~ II '(I! JI,"-
- 1. ~lu~t!~!.:I.!~~ -
*Expenditure per 
Province! capita(inpatients) for total 
National projected deaths 
(2003+2004) 
Central 1.4 
'-'---'.'---"'-'--'-- ... _._-_ .. _- -_._- -- - _ ... -
Copperbelt 
I--... --.----.-.-!:~---. .... -.. ---.... _ .. __ ._-- --
Eastern 0.9 .-_ ... _ ..... _---- . ._-_ .. __ .. _--- ---
Luapula 2.0 
'-'-'-'-"--'---------_._--- -







'/ 01', , 
; 
.Source: Adapted/rom Table 120 (column 4) 
•• Source: Adapted/rom Table 11 (column 6) 
- -
**Total projected 
deaths (2004 +2005) 











Basic formulas used to calculate projected expenditure for flIV/AIDS in 2004: 
- - --
ZProjected expenditure for 








24,6<!~ . ____ .. _ 
40,163 -----
21 121 -
_' .~ , .:: J 
Zprojected 2004 expenditure(inpatienls) = 
EXpenditure per capita(inpatients) for the total projected deaths for the 
years (2003 + 2004) X Total projected deaths for (2004 + 2005) 
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5.5.6 Comparison of estimated annual expenditure for HIV/AIDS 
patients in 2003 and projected expenditure for 2004 
(outpatients) 
Table 13c compares estimated annual outpatient expenditure for HIV I AIDS patients in 
2003 and the 2004 projected expenditure. The expenditure figures presented in Table 13c 
below were adapted from Table J3a (column 1) and Table J3b (column 4). The Table 
shows a similar pattern of an increase in expenditure for HIV I AIDS patients over the past 
two years. Expenditure for outpatients increased from US$314,073 in 2003 to 
US$321,373 in 2004. 
Provincel *Estimated annual expenditure **Projected expenditure for 
National for HIV/AIDS patients in HIV/AIDS patients in 2004(outpaliellls) 
2003(outpatienls) (in US$) 
Central 15,431 
Copperbelt 49,091 49,646 
Eastern 10,592 11,360 
Luapula 12,564 13,164 
Lusaka 154,388 157,646 
Northern 20,949 22,538 
North-Western 14,803 15,333 
Southern 24,803 25,102 
Western 12,600 12,907 
**Source: Table 1 
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Chapter overview: This chapter discusses results of key selected indicators. The 
indicators include expenditure on HIV/AIDS for outpatients and inpatients, expenditure 
per capita for outpatient visits and inpatient days. These indictors are discussed according 
to their geographical distribution and at different levels of health care. Section 6.1 
outlines utilisation statistics on outpatient visits and inpatient days compared according to 
their geographical distribution. Section 6.2 on the other hand, compares them by different 
levels of health care. Section 6.3 compares selected findings for this study and for other 
studies reviewed. 
6.1 Summary findings compared by different provinces 
Table 14 presents information on the utilisation of outpatient visits and inpatient days 
compared according to their geographical distribution. The Table shows that 
geographical inequalities exist in the distribution of resources among provinces. 
A look at the comparison between total projected number of deaths and expenditure by 
different provinces reveals that some provinces had relatively small numbers of projected 
AIDS deaths and yet had relatively large amount of resources. For example, Lusaka 
province with total projected AIDS deaths of31,871 in 2003 and 2004 combined, had an 
estimated expenditure of US$244,221 and US$154,388 on inpatients and outpatients 
respectively, whereas the Copperbelt province with total projected AIDS deaths of 
55,131 during the same period, had an estimated expenditure of US$77,656 and 
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Hospitals tend to be well equipped with medical supplies and have more qualified 
personnel such as medical doctors compared to the other provincial and district hospitals. 
Therefore, you would expect demand for health care to be higher at these hospitals. As 
Alderman and Lavy (1996) note, demand for health care is sensitive to the quality of 
services provided, implying that factors such as drug availability, staff skills and the 
general quality of health services provided at a given health facility might have an impact 
on the client's demand for health care. 
The other reason is that health facilities tend to be more accessible in the urban provinces 
in comparison with the rural provinces in terms of the distance that individuals need to 
travel to access the facility. High prevalence rates in urban settings could also account in 
some way to higher utilisation of health facilities. 
6.2 Summary findings compared at different levels of health care 
Table 15 presents data on utilisation of outpatient visits and inpatients days and estimated 
expenditure at different levels of health care. The Table shows a higher utilisation of 
health facilities at Third Level Hospitals than Second and First Level Hospitals. 
, t' _ Till'" I I' I' 'I 11111' I t 111 I, IIII I' \ i". . III I II u I; I I' \ I" I III I'll' I I; 
'\ I : I' I ii' .1 I 
- - - -
Level s 
of care IP days OPD visits 
Chapter 6: Discussions of key selected indicators 
Total estimated annual 
expend. on HIV/AIDS 
in USS (inpatients) 
Total estimated annual 
expend. on HIV/AIDS 
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Fourthly, various factors may impact on the cost per PDE for higher level hospitals and 
these include possible mix in diagnoses of patients and case severity; variations in quality 
of service and mix between outpatient and inpatient services supplied. In addition under-
utilisation of health services reflected in lower levels of health care might be an 
indication of poor services provided. Therefore, there is need to improve the general 
health services such as medical supplies and drugs and more qualified medical personnel 
at lower levels of health care. 
6.3 Comparison of selected findings for this study and for other studies 
reviewed 
A comparison of results on certain indicators for this study and other studies reviewed 
(i.e. those under the Chapter on literature review), yielded almost the same results. For 
example, results ofHIV/AIDS expenditure per capita on HIV positive population for this 
study was US$0.54 and that for a study conducted by Izazola et al (2002) in Guatemala 
on the same indicator was US$1.0S. However, the indicator compared was not exactly 
the same for the two countries due to differences in expenditures relative to the number 
of HIV positive people. In the case of Zambia whose utilisation data only cover public 
health institutions, data on outpatient visits are under reported since private health 
facilities are excluded. 
Results of annual outpatient visits per capita for the total population for this study was 
1.3 and that for a study conducted by Nandakumar et al (2001) in Rwanda on the same 
indicator was 0.29. As explained above, this difference could be due to differences in the 
completeness of utilisations figures used for the respective countries. 
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• Probabilistic Sensitivity Analysis: This type of sensitivity analysis allows the analyst to 
assign ranges and distributions to uncertain variable with an evaluation. 
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I !olr. ill- '1-, .. i I JI'." J!'~" 
, 
A,e "J -' • ill 1,,!l1) I I I ]I ~ , '>--11 .: / I r 1\ " .. d I~~ ll(. t II ~.I ~ I • \ . , 1" I. , I 
I .. .J ~ !. _1\ c ~ t ~ I ' ~ :, -II Ii ~ . , 'I, '_.LIt J1i::: ~ .. ~. '", ' ~. -, 
DllTerent OPD IPD Weighting 
VPDE(oulpalienls) Expenditure zUnit cost(oulpalienls) 
levels of Visits" Days" Factor (In US$)** (in US$) Ranking 
health care 
FLHs 2,270,112 102,238 3 783 ,272 10.5 13.4 I -_. - -_. __ ._-_._. 
SLHs 3,972,697 204,476 3 1,396,285 28.4 20.3 2 
--_. 
TLHs 5,107,753 374,873 3 1,907,198 76.3 40.0 3 
Assuming 10010 of the patients seen by private and mission hospitals are excluded from each of the three levels of care (i.e. hospitals) 
Source: 
*Table 16 (Colunm 3, Page 74) 
**Table 16 (Colunm 5, Page 74) 
Basic formulas used in Table 17b above: 
y 
PDE(oulpalienls) = (IP days I weighting factor) + (OPD visits); where the weighting metor is .3 
ZU' nIt cost(oUipalienls) = (Annual Expenditure in a given level of health care) 
PDE(oulpalienls) 
6.S Conclusion 
In conclusion, the observed disparities in expenditure per capita and utilisation of health 
services among provinces and different levels of health care have shown that health care 
supply tends to fuel further demands. In other words, as more resources are allocated to 
hospitals in urban provinces and less to hospitals in rural provinces, more patients tend to 
bypass the latter and attend the former. This scenario creates a vicious circle and existing 
disparities in the utilisation of health services widen. Therefore, concerned health 
authorities need to take measures aimed at strengthening the referral system within the 
Zambian health sector. 
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The study results have also shown that the cost per inpatient day and outpatient visit was 
significantly higher at Third Level Hospitals compared to the Second and/or First Level 
Hospitals. Results of the study are consistent with findings of other studies that show that 
the cost per inpatient day for hospitals at the tertiary level are significantly higher than 
those providing lower levels of care. However, the higher utilisation of services at Third 
Level Hospitals points to allocative inefficiency in resource allocation. Therefore, 
policymakers should focus on improving the quality of services at the lower levels of 
care in order to shift utilisation away from the more expensive facilities. 
The study has also projected the likely expenditure required to provide a given level of 
care to AIDS sick patients in coming years. Because the death rate associated with the 
Zambian HIV/AIDS epidemic will peak over the next three years, these projections show 
the additional expenditure that would be required to cater for these patients at the current 
level of care and at current expenditure levels. 
The study recommends that expenditure per capita for the AIDS sick population is a 
better indicator of need than expenditure per capita for the HIV -positive population. The 
concept of need for health care is generally related to 'ill-health '. Williams (1962) and 
Gillon (1986), both suggest that persons who are more ill than others have greater need. 
Therefore, it is against this background that we consider expenditure per capita for AIDS 
sick population a better indicator of need than HIV prevalence, since people who are sick 
are more in need of resources than those who are merely HIV positive but not yet sick. In 
addition, the observed disparities among provinces on the distribution of expenditure per 
capita for AIDS sick patients points to inequitable access to services, and this should call 
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7.2.1 Exclusion of data sources from the private sector, health posts 
and health centres 
Expenditure and utilisation data used in this report covered only public health care 
services, which included first, second and third level hospitals. Health posts and health 
centres were excluded from the analysis because of the non-curative services offered and 
scanty data on expenditure for these levels of care. Therefore, estimates of expenditure 
per capita on HIV / AIDS and overall utilisation of health facilities provided might not be 
a reflection of total expenditure on HIV-related care in the country. 
7.2.2 General problem with aggregated expenditure data 
One of the limitations of expenditure data collected for this study was that it was not 
possible to present expenditure data disaggregated into commodities and products (drugs 
and other medical supplies), or human resources. Because of institutional constraints, 
health facilities in Zambia do not need to report their expenditure by line items to the 
Central Board of Health. Furthermore, it has not been possible to disaggregate 
expenditure data into service delivery and programme level expenditure, where the 
former would relate to expenditure spent on facilities and the latter would relate to 
resources for the running of the Ministry of Health, Central Board of Health, district 
health offices and resources for centrally coordinated programmes such as health 
education campaigns. In other words, the unit cost estimates include resources that would 
normally not be allocated to patient services in cost analyses. While this implies that our 
unit costs are an overestimate, on the other hand it is important to include programme 
level costs because they can be substantial in magnitude. 
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Disease name 
Malaria 
Respiratory infection: non-pneumonia 
141,886 271,320 
133,396 100,136 233,532 
123,900 95,360 219,260 
52,714 157,515 210,229 
14,171 171,923 186,094 
2,923 175,476 178,399 
1,666 8,911 156,718 165,629 
2,315 72,042 85,142 157,184 
27,957 10,737 103,208 113,945 
771 108,838 109,609 
38,759 70,042 108,801 
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---------Inpatient days and outpatient visits for all diseases, Zambia, 2003--
Inpatient days • visits 
Disease name UnderS OverS Total UnderS OverS Total 
Poisoning 483 2,706 3,189 2,109 9,961 12,070 
Any perinatal conditions 7;158 * 7,158 
... 
10,708 * 10,708 
All other communicable diseases (total) 291 322 613 3,798 4,817 8,615 
.",up.aou' (all types) 101 3;003 3,104 366 8,132 8,498 
Mumps 16 
......1('; .... 
32 2,873 3,618 6,491 
Meningitis 957 3;169 4,126 1,0i 3,550 4,626 
:,·uDstance abuse 70 820 890 518 3,940 4,458 
Scabies 20 152 172 1,630 1,769 3,399 
u:prosy (SII<n""t"cl and confinned cases) * 113 113 * 1,863 1,863 
Diarrhoea with severe y,",u)'y.auu, . cholera) 156 741 ·897 343 985 1,328 
Hepatiti: 27 222 249 139 407 546 
Whooping Cough (pertussis) 47 16 63 293 98 391 
Anthrax 18 61 79 71 270 ·341 
Sleeping Sickness - trypanosomiasis * 2 2 103 116 219 
Typhoid fever 8 33 41 13 90 103 
Acute Flaccid Paralysis 28 20 48 47 31 78 
Rabies 19 34 53 19 34 53 
Neonatal Tetanus 26 * 26 39 0 39 
Diphtheria 8 9 17 17 14 31 
Tetanus (non neonatal) 13 7 20 18 12 30 
Onchocerciasis * * * 3 4 7 
Trachoma * * * * 3 3 
Plague * * * * * * 
Total for all diseases 346,387 410,932 .-: 11111lL:1RII 11.141.1"0 _ 
Source: CBoH. HMIS database. 2003 
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Year 
Province 2003 2004 2005 2006 2007 2008 2009 2010 
7,877 8,399 8,747 8,978 9,098 9,133 9,097 9,016 
27,704 27,609 27,553 27,477 27,405 27,275 27,094 26,799 
8,818 9,319 9,614 9,730 9,719 9,627 9,481 9,338 
4,761 4,995 5,131 5,204 5,232 5,234 5,224 5,209 
15,597 16,274 16,569 16,617 16,468 16,211 15,849 15,429 
5,712 6,103 6,418 6,657 6,807 6,901 6,949 6,958 
2,522 2,684 2,792 2,856 2,887 2,892 2,880 2,859 
12,143 12,524 12,578 12,586 12,574 12,541 12,485 12,403 
csa Epidemiological Projections, 2003. 
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